Logo

Tests Detect Alzheimer’s Risks, but Should Patients Be Told?

Marjie Popkin thought she had chemo brain, that fuzzy-headed forgetful state that she figured was a result of her treatment for ovarian cancer. She was not thinking clearly — having trouble with numbers, forgetting things she had just heard.

Click Here to read full article.


Depression Medicines

Not only does it take time to get an accurate depression diagnosis, finding the right medication to treat depression can be a complicated, delicate process. Someone may have a serious medical problem, such as heart disease or liver or kidney disease, that makes some antidepressants unsafe. The antidepressant could be ineffective for you, the dose inadequate, there hasn’t been enough time to see an effect, or side-effects are too bothersome — leading to a failure of treatment.

Read the full article at http://www.webmd.com/depression/guide/optimizing-depression-medicines


The Age of Alzheimer’s

By SANDRA DAY O’CONNOR, STANLEY PRUSINER and KEN DYCHTWALD
Published: October 27, 2010

OUR government is ignoring what is likely to become the single greatest threat to the health of Americans: Alzheimer’s disease, an illness that is 100 percent incurable and 100 percent fatal. It attacks rich and poor, white-collar and blue, and women and men, without regard to party. A degenerative disease, it steadily robs its victims of memory, judgment and dignity, leaves them unable to care for themselves and destroys their brain and their identity — often depleting their caregivers and families both emotionally and financially.

Click Here to read full article on the New York Times website…


Welcome to Keystone Clinical Studies

What is our Mission?

Our Mission is to improve lives of the patient community by helping to bring the most effective new medications to the market.

What do we do?

We test the Safety and Efficacy of investigational medications (Phase 2 to Phase 4 Trials) being developed by Pharmaceutical Sponsors to treat diseases of the Central Nervous System (CNS).

Why do we need new medications?

We conduct research studies for treating Alzheimer’s disease, Generalized Anxiety Disorder, Major Depression, Bipolar Disorder, and Schizophrenia.

These are disorders for which there is no ‘cure’; also, a significant proportion of patients are ‘treatment resistant.’

Therefore, new medications are urgently needed to improve quality of life & alleviate symptoms, increase efficacy for more people, reduce the intensity and frequency of occurrences, reduce side effects of current medications.

A prime example is Alzheimer’s Disease, a serious and debilitating brain disorder, which has no cure at the present time. We are working on a series of clinical trials, which we hope will pave the path to finding a cure in the future.

Why do we need Clinical Trials?

Pharmaceutical companies (called Sponsors) who are engaged in developing new medications start with extensive laboratory testing in animals and human cells. If successful, they send data to the FDA for approval to continue testing on human subjects. The Food and Drug Administration (FDA) of the US Government requires Pharmaceutical Sponsors to conduct clinical trials, before they can approve new prescription drugs for sale in the US.

Without this key step (conducting successful clinical trials with human subjects), we will not be able to bring new medications to the patient (consumer). Clinical trials are imperative for the process of improving treatment outcomes for millions of patients suffering from chronic or life-threatening conditions.